L umbar spinal stenosis (LSS) is a common cause of chronic low back, lower extremity pain, and intermittent claudication, particularly in elderly patients. 1, 2 The ligamentum flavum (LF) covers a considerable part of the posterior and lateral walls of the spinal canal. LF hypertrophy has been considered as a major contributor to the development of LSS. 3, 4 Hypertrophy of LF results from LF degeneration brought about by tissue inflammation and fibrosis. Several molecules participate in the pathological process. Regarding fibrosis of the LF, transforming growth factor b1 (TGF-b1), matrix metalloproteinases (MMPs), and tissue inhibitors of matrix metalloproteinase (TIMPs), which are key factors in tissue fibrosis, are the molecules underlying the mechanism of LF hypertrophy. [5] [6] [7] [8] Moreover, inflammation of LF tissue also contributes to LF hypertrophy. 1, 2, 9, 10 Although fibrosis and inflammation have been postulated to be the main cause of LF hypertrophy, the precise pathogenesis of LF hypertrophy remains unclear so far.
In recent years, microRNAs (miRNAs) have emerged as key players in the pathogenesis of many diseases. 11 MiRNAs are small noncoding RNA molecules that modulate the expression of multiple protein-encoding genes at the posttranscriptional level. These molecules participate in nearly every developmental and physiologic process, which have been found to regulate a variety of cellular processes such as cell proliferation, differentiation, migration, and inflammation. [12] [13] [14] On the basis of the above-mentioned evidence, miRNAs may play a critical role in the pathogenesis of LF hypertrophy. Thus, establishment of a miRNA expression profile is important for investigating the underlying functional mechanisms for LF hypertrophy, and a better knowledge of their expression patterns could reveal molecular signatures that can be developed as therapeutic targets as well.
In the present study, we performed comprehensive miRNA profiling using a miRNA microarray, identified several LF hypertrophy specific miRNAs, and discovered miR-221 expression to be significantly downregulated in LF tissues of patients with LSS compared with control tissues. Subsequently, we systematically validated the role of miRNA-221 in a series of experiments performed in culture of human LF cells. Moreover, bioinformatics target prediction identified tissue inhibitors of matrix metalloproteinase 2 (TIMP-2) as a putative target of miR-221. Luciferase reporter assays demonstrated that miR-221 directly targets TIMP-2 and affects the protein expression of TIMP-2 in fibroblasts isolated from LF.
MATERIALS AND METHODS

Subjects
Between May 2013 and July 2014, a total of 48 samples of LF tissue were obtained from 48 patients who underwent decompression because of neurogenic claudication due to LSS that had been unresponsive to conservative measures for at least 3 months. Of them, 10 LF specimens were used for miRNA microarrays screening. None of these patients received epidural or selective nerve-root blocks. Thirty-two patients were female, and 16 were male. The mean age of the patients at the time of surgery was 66.7 AE 7.1 years (range, 58-77 years). Patients with isthmic or degenerative spondylolisthesis, lumbar disc herniation, ankylosing spondylitis, or diffuse idiopathic skeletal hyperostosis were excluded from the study. Twenty-six patients underwent a 1-level operation; 13, a 2-level operation; and 9, a 3-level operation. We randomly selected 32 gender-matched control patients with lumbar disc herniation (LDH) from a group of 98 patients who were being operatively managed for that disorder. The mean age of the control patients was 36.5 AE 3.2 years (range, 32-38 years), which was significantly younger than the mean age of the patients with LSS (P < 0.01). Of them, 10 LF specimens were used for miRNA microarrays screening. The characteristics of patients in each group are summarized in Table 1 . The entire layer of the central portion of the LF was obtained, and the epidural fat from the LF tissues was removed. All tissues were stored in a liquid nitrogen tank immediately after harvesting and kept at À808C until experiments were performed. This study protocol was approved by the Ethics Committee of our institution, and written informed consent was obtained from each participant.
LF Thickness Measurement
An axial T1-weighted magnetic resonance image (repetition time, 600 msec; echo time, 30 msec) was performed, with a 1.5-T unit (Somatom Plus; Siemens, Erlangen, Germany), at the facet joint level of the lesion for each patient. The maximum thickness of the LF was traced with use of the manual cursor technique and was computed automatically by the installed software in the magnetic resonance imaging scanner. All of the radiographic analyses were independently performed by 2 experienced spine surgeons who were not involved in the care of the patients. Each observer independently measured the LF thickness twice, and the average of the four measurements was used as the final thickness.
Culture of Human LF Fibroblast Cells
LF cells were isolated from the ligament as follows. Briefly, the ligaments were washed with PBS several times, minced into small pieces, and digested in serum-free medium (Gibco) containing 250 U/mL type I collagenase (Sigma) at 378C in an atmosphere containing 5% CO 2 . The digested specimens were washed with serum-containing medium to inhibit collagenase activity and then placed in 35 mm dishes in Dulbecco's Modified Eagle Medium and Ham's F-12 medium (DMEM/F12; Gibco) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco-BRL). The cultures were incubated at 378C in a humidified atmosphere containing 5% CO 2 . The medium was changed every 2 days. After 2 weeks, cells began to migrate from the ligament chips and formed a monolayer. The cells were maintained for 2 to 3 weeks in DMEM/F12 containing 10% FBS, 1% v/v penicillin, and streptomycin (Sigma) in an incubator with a humidified atmosphere containing 5% CO 2 . Subsequent experiments were conducted using cells from the second to the fourth passage.
Dual Luciferase Assays
The cells were co-transfected with 0.4 mg reporter construct, 0.2 mg pGL-3 control vector, and either miR-221 or a Oligonucleotides, Constructs, and Transfections miR-221 mimic, miR-221 inhibitor, and the negative controls were purchased from Dharmacon (Chicago, IL,) and were transfected into the cells with final oligonucleotide concentration of 100 nmol/L. All cell transfections were performed using DharmaFECT1 reagent (Dharmacon, Austin, TX), according to the manufacturer's instructions. For each cell transfection, 3 replicate experiments were performed.
RNA Isolation
Total RNA from LF tissues and sera was isolated by TRIzol (Invitrogen, Carlsbad, CA) and RNeasy mini kit (Qiagen, Valencia, CA) according to the manufacturers' protocol. Subsequently, RNA was eluted in 50 mL of nuclease-free water, and stored at À808C for further analysis. The RNA concentration was measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE).
miRNAs Microarray
For miRNA profiling, total RNA from LF tissues was analyzed using the low-density TaqMan Array Human MicroRNA Cards A þ B Set v2.0 (Applied Biosystems, Foster City, CA) according to the manufacturer's protocol. This array card set contains a total of 987 TaqMan miRNA assays per card and enables assaying of 726 specific human microRNA. Then, significance analysis of microarray (SAM) (version 4.0) was performed to select miRNAs (Stanford University). Hierarchical cluster analysis was conducted using Gene Cluster 3.0 software (Stanford University).
Reverse Transcription (RT) and Quantitative Real-Time PCR (qPCR)
To determine miRNA levels in LF samples, RT and qPCR kits (Applied Biosystems, Foster City, CA) were used. RT reactions were performed using the TaqMan microRNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) in a final volume of 15 mL (168C for 30 min, 428C for 30 min, 858C for 5 min, and hold at 48C). For real-time PCR, the reaction mix contains 10 mL TaqMan Universal PCR Master Mix with no AmpErase UNG, 0.5 mL miRNA TaqMan primers, 4 mL diluted RT product, and 5.5 mL nuclease-free water. All reactions were preformed in triplicate on a 7500 Real-time system (Applied Biosystems, Foster City, CA) with the following conditions: 958C for 10 min, followed by 40 cycles at 958C for 15 s, and 608C for 1 min. The threshold cycle (CT) is defined as the fractional cycle number at which the fluorescence exceeds the given threshold. The CT values from real-time PCR assays greater than 40 were treated as 40. All miRNA quantification data were normalized to U6 expression and mRNA quantification data were normalized to GAPDH. Relative amounts of transcript were calculated using the comparative Ct method.
Western Blotting
According to standard methods, western blot analysis was performed. Proteins were separated on 10% SDS-PAGE gel and then transferred to PVDF membranes (Amersham, Buckinghamshire, UK), which were blocked using 5% non-fat dried milk for 2 h, and incubated for 12 h with anti-type collagen I and III antibody (1 : 1000; Abcam, Cambridge, UK), anti-TIMP-2 antibody (1 : 1000; Bioworlde, Minneapolis, MN), or anti-GAPDH antibody (1:50,000; Proteintech, Chicago, IL). After washing in TBST (10 mM Tris, pH 8.0, 150 mM NaCl, and 0.1% Tween 20), membranes were incubated for 2 h in goat anti-rabbit antibody (1 : 1000; Abcam, Cambridge, UK). The results were normalized using GAPDH.
Statistical Analysis
All statistical analyses were performed using SPSS 17.0 software (SPSS Inc, Chicago, IL), and graphs were generated using GraphPad Prism 5 Software (Graph Pad Software, Inc, La Jolla, CA). The difference in the fold change of miRNAs between patients and controls was assessed by independent-samples t test, whereas the difference in miRNA concentration between these 2 groups was analyzed using Kruskal-Wallis test. The Pearson correlation coefficient was performed to evaluate the associations between the expression of miR-221 and expression of collagen I and collagen III in fibroblasts isolated from LF. P value less than 0.05 was considered statistically significant.
RESULTS
LF Thickness
The mean thickness of the LF was 6.2 AE 2.3 mm (range, 4.3-6.9 mm) in the patients with LSS and 2.6 AE 1.8 mm (range, 1.9-3.2 mm) in those with LDH. The difference was significant (P < 0.001).
TaqMan MicroRNA Array of miRNAs in Patients and Controls
Of 538 miRNAs detected by microRNA array, 56 miRNAs were differentially expressed in patients when compared with controls, including 38 upregulated and 18 downregulated miRNAs. These differentially expressed serum miRNAs were chosen for further study only when they met the following criteria 15 : (1) having at least 20 copies of miRNA expression; (2) mean fold change more than 2 or less than 0.5; and (3) P values less than 0.05. On the basis of these criteria, 18 miRNAs, of which 15 miRNAs were upregulated and 3 miRNAs were downregulated in patients compared with controls, were chosen for further analysis (Figure 1 ).
qRT-PCR assay was used to confirm the expression of candidate miRNAs. In the training set, miRNAs were measured in a separate set of samples from 10 patients and 10 controls of the previous step. Only miRNAs with a mean fold change more than 2 or less than 0.5 and a P value less than 0.01 were selected for further analysis. Using the above-mentioned criteria, miR-202-3p, miR-486, and miR-221 were observed to be significantly dysregulated in patients compared with controls (Table 2 ).
In the validation set, the concentration of miR-202-3p, miR-486, and miR-221 were measured by qRT-PCR in a larger cohort comprising 38 patients and 22 controls. The miR-221 expression pattern in the validation set was consistent with those in the training set. Compared with the controls, the level of miR-221 was significantly lower in patients with LSS (Table 2 ). The differential level of miR-221 between 48 patients and the 32 controls was demonstrated in Figure 2A . Interestingly, serum miR-221 expression pattern was similar to that in LF tissues ( Figure 2B ). In addition, the mRNA expression levels of both collagens I and III were increased significantly in LF samples from LSS group ( Figure 2C ). The expression of collagens I and III protein was also higher in LF samples from LSS group than that from LDH group ( Figure 2D ).
Overexpression of miR-221 Inhibited Expression of Collagens I and III in LF Cells
LF cells were transfected with scrambled control oligo or with miR-221 mimic, both of which had high transfection efficiency ( Figure 3A) . RT-qPCR assay demonstrated that collagens I and III were reduced in cells that were transfected with miR-221 mimic compared with scrambled oligo-transfected cells or untreated cells ( Figure 3B ,C).
MiR-221 Downregulated TIMP-2 Expression
As predicted by miRanda (http://www.microrna.org/), TargetScan (http://www.targetscan.org/), PicTar (http:// pictar.mdc-berlin.de/), and PITA (http://genie.weizmann.ac. il/pubs/mir07/mir07), there was complementarity between miR-221 and TIMP-2 3'UTR. To demonstrate a direct interaction between miR-221 and TIMP-2, we performed luciferase reporter assays with a TIMP-2 vector that contained either the putative miR-221 binding sites (wild-type) or the mutant-binding sites (MUT) that were contained in the 3'UTR ( Figure 4A ). Overexpression of miR-221 significantly reduced luciferase activity of the reporter gene in wild type, but not mutant, indicating that miR-221 directly targeted the TIMP-2 3'UTR ( Figure 4B ). This effect was further confirmed by gene and protein expression. As shown in Figure 4C ,D, overexpression of miR-221 reduced both TIMP-2 protein and mRNA levels in LF cells. 
The Role of TIMP-2 in the Function of miR-221 in LF Cells
To further validate that targeting TIMP-2 was involved in the function of miR-221 in LF cells, the rescue experiments were performed. TIMP-2 expression vector was used to restore TIMP-2 expression. Upregulation of collagens I and III mRNA and protein expression, which was induced by inhibition of miR-221, was significantly enhanced by reintroduction of TIMP-2 ( Figure 5A-C) .
The TIMP-2 Expression Level in LF Tissues
The expression level of TIMP-2 was significantly upregulated in LSS group when compared with LDH group ( Figure 6A ). Furthermore, the expression level of TIMP-2 was negatively correlated with miR-221 level (r ¼ À0.89, P < 0.001) ( Figure 6B ).
DISCUSSION
In this study, using microRNA array, miR-221 was selected for further study. MiR-221 was found to be significantly downregulated in LF tissues of patients with LSS. The mRNA and protein expression levels of both collagens I and III were increased significantly in LF samples from LSS group. Moreover, overexpression of miR-221 reduced expression of collagens I and III in LF cells. Notably, we also identified TIMP-2 to be a direct target of miR-221. TIMP-2 was upregulated in human LF tissues compared with controls and the expression of TIMP-2 negatively correlated with miR-221 expression. Furthermore, the reduced expression of collagens I and III after miR-221 overexpression was almost completely blocked by TIMP-2.
Recent studies have revealed an important role of miRNAs in multiple cell processes, including proliferation, apoptosis, inflammation, fibrosis, and extracellular matrix (ECM) degradation. [16] [17] [18] In the process of LF hypertrophy, there may exist specific miRNA expression profile associated with it. To the best of our knowledge, this is the first study describing the relationship between LF hypertrophy and miRNA expression. In the current study, using micro-RNA array, we found that miR-221 expression level was significantly lower in patients with LSS ( Figure 2A ). In addition, the mRNA and protein expression levels of both collagens I and III were higher in LF samples from LSS group (Figure 2C,D) . Although the exact mechanism of LF hypertrophy is not completely understood, it is generally thought to be the result of fibrosis and inflammation. 1, 2, 5, [8] [9] [10] The definitive biochemical feature of LF hypertrophy is the increase of collagens I and III. Current evidence implicates that increase of collagens I and III is considered to be an early indicator of LF hypertrophy. [1] [2] [3] [4] [5] [6] [7] [8] 19, 20 To further investigate the role of miR-221 in pathogenesis of LF hypertrophy, we performed functional analysis of miR-221 to investigate the relationship between miR-221 and collagens I and III expression. Overexpression of miR-221 significantly reduced expression of collagens I and III in LF cells ( Figure 3A-C) . These findings suggest that increased collagens I and III expression induced by downregulation of miR-221 might participate in LF hypertrophy.
For further insight into the function of miR-221, we performed target searches and validation. TIMP-2, a major member of proteins of TIMP family, is involved in suppression of the breakdown of ECM in normal physiological processes, such as embryonic development, reproduction, 
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MicroRNA-221 Regulates Ligamentum Flavum Hypertrophy by Targeting TIMP-2 Xu et al and tissue remodeling, as well as in disease processes, such as arthritis and intervertebral disc degeneration. TIMP-2 also has other important biological functions, including promotion of cellular proliferation and inhibition of apoptosis (programmed cell death) in a wide range of cell types. [21] [22] [23] In our study, TIMP-2 was found to have a putative binding site for miR-221, and western blotting confirmed the expression of TIMP-2 in LF cells. Moreover, TIMP-2 protein expression in LF cells was suppressed by miR-221 mimic that has been shown to behave similarly to mature endogenous miR-221, but not by miR-221 scramble, which is an oligonucleotide that does not interact with its target (Figure 4A-D) . In addition, upregulation of collagens I and III mRNA and protein expression, which was induced by inhibition of miR-221, was significantly enhanced by re-introduction of TIMP-2 ( Figure 5A-C) . These results indicate that miR-221 may inhibit the expression of TIMP-2. Several previous studies have demonstrated that LF cells in LSS express excessive TIMPs, which can suppress ECM degradation. The hallmark of LF hypertrophy is progressive increase of ECM macromolecules aggrecan and collagens II and III. [1] [2] [3] [4] [5] [6] [7] [8] 19, 20 Of note, high expression level of TIMP-2 was observed in LF tissues of LSS patients, suggesting that TIMP-2 can promote ECM components such as collagens I and III, aggrecan, and fibrosis. 7 We also found that TIMP-2 was upregulated in LSS group compared with LDH group (Figure 6A) , and expression level of TIMP-2 negatively correlated with miR-221 expression ( Figure 6B ). It is considered that the downregulation of miR-221 expression increased TIMP-2, thereby promoting excessive ECM components such as collagens I and III, and might be the potential mechanism in LF hypertrophy.
Two limitations of our study should be addressed. First, the patients with LSS were significantly older than those with LDH. Therefore, we cannot exclude the possibility that the natural aging process had an impact on the LF Figure 6 . Compared with LDH, the expression level of TIMP-2 was significantly upregulated in LF tissues of LSS group (A). In addition, the expression level of TIMP-2 was negatively correlated with miR-221 level (r ¼ -0.89, P < 0.001) (B). hypertrophy. It would have been ideal to have 2 different controls: age and gender-matched specimens from patients without stenosis and gender-matched specimens from lateteenagers. The former would eliminate age as an independent variable. Specimens from late-teenagers who have no any degenerative changes would allow us to determine the extent of the perturbations occurring in LSS. Unfortunately, both of these ideal controls rarely undergo surgical treatment, making it nearly impossible to gather enough samples. In fact, young disc herniation group was frequently used as a control group. 4, 7 Second, our study merely analyzed the influence of miR-221 on collagen I and III expressions. However, whether miR-221 exerts effects on other types of collagen is unclear. It is very important to elucidate the relationship between miR-221 and other types of collagen. This relationship will be investigated in our following miRNA studies.
In conclusion, we identified that miR-221 was lower in LF tissues of patients with LSS. In addition, its inhibitory effects are, in part, mediated through its downstream target gene, TIMP-2. Using cell culture, functional characterization for the role of miR-221 reveals that loss of its expression is an early event in LF hypertrophy. Therefore, strategies to maintain the expression or to prevent the repression of miR-221 have the potential to become a possible therapeutic strategy for LSS.
Key Points
This is the first study specially focusing on miRNA expression profile in LF tissues of patients with LSS. We identified that miR-221 was lower in LF tissues of patients with LSS. In addition, the mRNA and expression levels of collagens I and III were higher in LF samples from LSS group. The downregulation of miR-221 might contribute to LF hypertrophy by promoting collagens I and III expression via the induction of TIMP-2.
